Head-to-head · WeighScore
Tyde Wellness vs Vaylen
By GLP-1 ScorecardUpdated
Score comparison
Tyde Wellness has the higher recorded score — 79.8/100 to 77.9/100, but only just.
Tyde Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tyde advertises compounded GLP-1 injections with online clinician review and follow-up support. Vaylen is close behind and may still be the better fit — see the factor split below.
Before you choose
Before comparing the headline prices, the Tyde Wellness review and the Vaylen review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Tyde Wellness vs Vea Health and Alloy vs Vaylen compare each of them with another graded program, and the list of alternatives to Tyde Wellness ranks the programs closest to Tyde Wellness on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Strut Health review covers one graded close to these two, at 79.4/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Tyde Wellness | Vaylen |
|---|---|---|
| WeighScore | 79.8/100 | 77.9/100 |
| Grade | C+ | C+ |
| Site position | #39 | #45 |
| Semaglutide | $88 starting price (compounded injection; billing interval unconfirmed) | $99/mo advertised (monthly option; conflicting annual totals) |
| Tirzepatide | $125 starting price (compounded injection; billing interval unconfirmed) | From $99/mo (12-month prepaid equivalent; monthly-plan price not confirmed) |
| Coverage | All 50 states | Public disclosures differ between 49 and 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Advertises a free consultation
- Publishes membership cancellation instructions
What to consider
- Headline prices do not specify the billing interval
- Refunds after renewal are discretionary under membership terms
Strengths
- Shows a separate month-to-month semaglutide option
- Advertises injectable and oral compounded options
- Describes cancellation through the patient portal for monthly plans
What to consider
- The annual semaglutide card shows $828 and the FAQ states $996
- The offer and terms describe different payment timing and clinical groups
- Confirm coverage, the dispensing pharmacy and any named branded drug with the provider
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.